| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential
|
Schultze-Mosgau, Marcus-Hillert
|
|
2018
|
57 |
8 |
p. 1001-1015
|
artikel
|
| 2 |
Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
|
Hemperly, Amy
|
|
2018
|
57 |
8 |
p. 929-942
|
artikel
|
| 3 |
Correction to: Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic
|
Kleideiter, Elke
|
|
2018
|
57 |
8 |
p. 1057-1058
|
artikel
|
| 4 |
Correction to: Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials
|
Dijkman, Sven C. van
|
|
2018
|
57 |
8 |
p. 1055-1056
|
artikel
|
| 5 |
Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics
|
Gandhi, Yash
|
|
2018
|
57 |
8 |
p. 911-928
|
artikel
|
| 6 |
Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials
|
Dijkman, Sven C. van
|
|
2018
|
57 |
8 |
p. 1039-1053
|
artikel
|
| 7 |
Evaluation of Tobramycin Exposure Predictions in Three Bayesian Forecasting Programmes Compared with Current Clinical Practice in Children and Adults with Cystic Fibrosis
|
Burgard, Marc
|
|
2017
|
57 |
8 |
p. 1017-1027
|
artikel
|
| 8 |
Industry Perspective on Standardizing Food-Effect Studies for New Drug Development
|
Marroum, Patrick J.
|
|
2018
|
57 |
8 |
p. 901-909
|
artikel
|
| 9 |
Methods of Estimating Kidney Function for Drug Dosing in Special Populations
|
Hart, Laura A.
|
|
2018
|
57 |
8 |
p. 943-976
|
artikel
|
| 10 |
Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease
|
Facius, Axel
|
|
2018
|
57 |
8 |
p. 1029-1038
|
artikel
|
| 11 |
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients
|
Cojutti, Piergiorgio
|
|
2017
|
57 |
8 |
p. 989-1000
|
artikel
|
| 12 |
Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I and II Clinical Trials
|
Klünder, Ben
|
|
2017
|
57 |
8 |
p. 977-988
|
artikel
|
Tijdschrift beschrijving